Triazolam (Triazolam) - Indications and Dosage

INDICATIONS AND USAGE

Triazolam is indicated for the short-term treatment of insomnia (generally 7–10 days). Use for more than 2–3 weeks requires complete reevaluation of the patient (see WARNINGS).

Prescriptions for triazolam should be written for short-term use (7–10 days) and it should not be prescribed in quantities exceeding a 1-month supply.

DOSAGE AND ADMINISTRATION

It is important to individualize the dosage of triazolam tablets for maximum beneficial effect and to help avoid significant adverse effects.

The recommended dose for most adults is 0.25 mg before retiring. A dose of 0.125 mg may be found to be sufficient for some patients (e.g., low body weight). A dose of 0.5 mg should be used only for exceptional patients who do not respond adequately to a trial of a lower dose since the risk of several adverse reactions increases with the size of the dose administered. A dose of 0.5 mg should not be exceeded.

In geriatric and/or debilitated patients the recommended dosage range is 0.125 mg to 0.25 mg. Therapy should be initiated at 0.125 mg in these groups and the 0.25 mg dose should be used only for exceptional patients who do not respond to a trial of the lower dose. A dose of 0.25 mg should not be exceeded in these patients.

As with all medications, the lowest effective dose should be used.

HOW SUPPLIED

Triazolam tablets are available in the following strengths and package sizes:

0.125 mg (white,, imprinted G3717):

10–10 Tablet Bottles                            NDC 59762-3717-4

0.25 mg (powder blue, scored, imprinted G3718):

10–10 Tablet Bottles                            NDC 59762-3718-4

Bottles of 500                                       NDC 59762-3718-3

Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].

Rx only